Ignite Creation Date:
2024-06-16 @ 11:51 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06456580
Status:
RECRUITING
Last Update Posted:
2024-06-13
First Post:
2024-06-07
Brief Title:
A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis RemeMG
Sponsor:
RemeGen Co Ltd
Organization:
RemeGen Co Ltd
Organization Data
Organization:
RemeGen Co Ltd
Class:
INDUSTRY
Study ID:
RC18G006
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
RemeGen Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None